<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35785029</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-7156</ISSN><JournalIssue CitedMedium="Internet"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Journal of immunology research</Title><ISOAbbreviation>J Immunol Res</ISOAbbreviation></Journal><ArticleTitle>Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence.</ArticleTitle><Pagination><StartPage>9534163</StartPage><MedlinePgn>9534163</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9534163</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2022/9534163</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19), a pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, can affect almost all systems and organs of the human body, including those responsible for reproductive function in women. The multisystem inflammatory response in COVID-19 shows many analogies with mast cell activation syndrome (MCAS), and MCAS may be an important component in the course of COVID-19. Of note, the female sex hormones estradiol (E<sub>2</sub>) and progesterone (P4) significantly influence mast cell (MC) behavior. This review presents the importance of MCs and the mediators from their granules in the female reproductive system, including pregnancy, and discusses the mechanism of potential disorders related to MCAS. Then, the available data on COVID-19 in the context of hormonal disorders, the course of endometriosis, female fertility, and the course of pregnancy were compiled to verify intuitively predicted threats. Surprisingly, although COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in MCAS, the available clinical data do not provide grounds for treating this mechanism as significantly increasing the risk of abnormal female reproductive function, including pregnancy. Further studies in the context of post COVID-19 condition (long COVID), where inflammation and a procoagulative state resemble many aspects of MCAS, are needed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Dariusz Szukiewicz et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szukiewicz</LastName><ForeName>Dariusz</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0124-060X</Identifier><AffiliationInfo><Affiliation>Department of Biophysics Physiology &amp; Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojdasiewicz</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3309-996X</Identifier><AffiliationInfo><Affiliation>Department of Biophysics Physiology &amp; Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watroba</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4077-3641</Identifier><AffiliationInfo><Affiliation>Department of Biophysics Physiology &amp; Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szewczyk</LastName><ForeName>Grzegorz</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4143-2777</Identifier><AffiliationInfo><Affiliation>Department of Biophysics Physiology &amp; Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Egypt</Country><MedlineTA>J Immunol Res</MedlineTA><NlmUniqueID>101627166</NlmUniqueID><ISSNLinking>2314-7156</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090267" MajorTopicYN="Y">Mast Cell Activation Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008415" MajorTopicYN="Y">Mastocytosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="Y">Pregnancy Complications, Infectious</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>5</Day><Hour>10</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35785029</ArticleId><ArticleId IdType="pmc">PMC9242765</ArticleId><ArticleId IdType="doi">10.1155/2022/9534163</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li F., Lu H., Zhang Q., et al. Impact of COVID-19 on female fertility: a systematic review and meta-analysis protocol. BMJ Open. . 2021;11(2, article e045524) doi: 10.1136/bmjopen-2020-045524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045524</ArticleId><ArticleId IdType="pmc">PMC7908052</ArticleId><ArticleId IdType="pubmed">33632754</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T. C., Conti P. COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome? J Biol Regul Homeost Agents . 2020;34(5):1633&#x2013;1636. doi: 10.23812/20-EDIT3.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-EDIT3</ArticleId><ArticleId IdType="pubmed">33023287</ArticleId></ArticleIdList></Reference><Reference><Citation>Zierau O., Zenclussen A. C., Jensen F. Role of female sex hormones, estradiol and progesterone, in mast cell behavior. Front Immunol. . 2012;3:p. 169. doi: 10.3389/fimmu.2012.00169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00169</ArticleId><ArticleId IdType="pmc">PMC3377947</ArticleId><ArticleId IdType="pubmed">22723800</ArticleId></ArticleIdList></Reference><Reference><Citation>Valent P., Akin C., Hartmann K., et al. Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich's visions to precision medicine concepts. Theranostics. . 2020;10(23):10743&#x2013;10768. doi: 10.7150/thno.46719.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.46719</ArticleId><ArticleId IdType="pmc">PMC7482799</ArticleId><ArticleId IdType="pubmed">32929378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S. K., Kim C. J., Kim D. J., Kang J. H. Immune cells in the female reproductive tract. Immune Netw. . 2015;15(1):16&#x2013;26. doi: 10.4110/in.2015.15.1.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2015.15.1.16</ArticleId><ArticleId IdType="pmc">PMC4338264</ArticleId><ArticleId IdType="pubmed">25713505</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell W. M., Hanahoe T. H. A novel source of mast cells: the human placenta. Agents Actions. . 1991;33(1-2):8&#x2013;12. doi: 10.1007/BF01993113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01993113</ArticleId><ArticleId IdType="pubmed">1716842</ArticleId></ArticleIdList></Reference><Reference><Citation>Csaba G. Mast cell, the peculiar member of the immune system: a homeostatic aspect. Acta Microbiol Immunol Hung. . 2015;62(3):207&#x2013;231. doi: 10.1556/030.62.2015.3.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/030.62.2015.3.1</ArticleId><ArticleId IdType="pubmed">26551566</ArticleId></ArticleIdList></Reference><Reference><Citation>Grootens J., Ungerstedt J. S., Nilsson G., Dahlin J. S. Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells. Blood Adv. . 2018;2(17):2273&#x2013;2281. doi: 10.1182/bloodadvances.2018019539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2018019539</ArticleId><ArticleId IdType="pmc">PMC6134220</ArticleId><ArticleId IdType="pubmed">30206100</ArticleId></ArticleIdList></Reference><Reference><Citation>Frossi B., Mion F., Sibilano R., Danelli L., Pucillo C. E. M. Is it time for a new classification of mast cells? What do we know about mast cell heterogeneity? Immunol Rev. . 2018;282(1):35&#x2013;46. doi: 10.1111/imr.12636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12636</ArticleId><ArticleId IdType="pubmed">29431204</ArticleId></ArticleIdList></Reference><Reference><Citation>Atiakshin D., Buchwalow I., Samoilova V., Tiemann M. Tryptase as a polyfunctional component of mast cells. Histochem Cell Biol. . 2018;149(5):461&#x2013;477. doi: 10.1007/s00418-018-1659-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-018-1659-8</ArticleId><ArticleId IdType="pubmed">29532158</ArticleId></ArticleIdList></Reference><Reference><Citation>Atiakshin D., Buchwalow I., Tiemann M. Mast cell chymase: morphofunctional characteristics. Histochem Cell Biol. . 2019;152(4):253&#x2013;269. doi: 10.1007/s00418-019-01803-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-019-01803-6</ArticleId><ArticleId IdType="pubmed">31392409</ArticleId></ArticleIdList></Reference><Reference><Citation>Woidacki K., Jensen F., Zenclussen A. C. Mast cells as novel mediators of reproductive processes. Front Immunol. . 2013;4:p. 29. doi: 10.3389/fimmu.2013.00029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00029</ArticleId><ArticleId IdType="pmc">PMC3572638</ArticleId><ArticleId IdType="pubmed">23419968</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies F. M., Shepherd M. C., Nibbs R. J., Nelson S. M. The role of mast cells and their mediators in reproduction, pregnancy and labour. Hum Reprod Update. . 2011;17(3):383&#x2013;396. doi: 10.1093/humupd/dmq053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humupd/dmq053</ArticleId><ArticleId IdType="pubmed">20959350</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi Y., Shima Y., Takeshita T., Morita R. Harmful and beneficial effects of inflammatory response on reproduction: sterile and pathogen-associated inflammation. Immunol Med. . 2021;44(2):98&#x2013;115. doi: 10.1080/25785826.2020.1809951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/25785826.2020.1809951</ArticleId><ArticleId IdType="pubmed">32838688</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto J., Kanayama N., Asahina T., Okada Y., Kobayashi T., Terao T. Induction of follicular growth by exogenous interleukin-8. Hum Reprod. . 1997;12(12):2729&#x2013;2734. doi: 10.1093/humrep/12.12.2729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/12.12.2729</ArticleId><ArticleId IdType="pubmed">9455844</ArticleId></ArticleIdList></Reference><Reference><Citation>Szukiewicz D., Pyzlak M., Klimkiewicz J., Szewczyk G., Maslinska D. Mast cell-derived interleukin-8 may be involved in the ovarian mechanisms of follicle growth and ovulation. Inflamm Res. . 2007;56(Suppl 1):S35&#x2013;S36. doi: 10.1007/s00011-006-0517-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-006-0517-7</ArticleId><ArticleId IdType="pubmed">17806170</ArticleId></ArticleIdList></Reference><Reference><Citation>Field S. L., Dasgupta T., Cummings M., Orsi N. M. Cytokines in ovarian folliculogenesis, oocyte maturation and luteinisation. Mol Reprod Dev. . 2014;81(4):284&#x2013;314. doi: 10.1002/mrd.22285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrd.22285</ArticleId><ArticleId IdType="pubmed">24273059</ArticleId></ArticleIdList></Reference><Reference><Citation>Szukiewicz D., Klimkiewicz J., Pyzlak M., Szewczyk G., Maslinska D. Locally secreted histamine may regulate the development of ovarian follicles by apoptosis. Inflamm Res. . 2007;56(Suppl 1):S33&#x2013;S34. doi: 10.1007/s00011-006-0516-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-006-0516-8</ArticleId><ArticleId IdType="pubmed">17806169</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna A., Beesley K., Terranova P. F. Histamine, mast cells and ovarian function. J Endocrinol. . 1989;120(3):363&#x2013;371. doi: 10.1677/joe.0.1200363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/joe.0.1200363</ArticleId><ArticleId IdType="pubmed">2647889</ArticleId></ArticleIdList></Reference><Reference><Citation>Szukiewicz D., Szewczyk G., Klimkiewicz J., Pyzlak M., Maslinska D. The role of histamine and its receptors in the development of ovarian follicles in vitro. Inflamm Res. . 2006;55(Suppl 1):S49&#x2013;S50. doi: 10.1007/s00011-005-0037-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-005-0037-x</ArticleId><ArticleId IdType="pubmed">16705380</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe3;o A. M., Skarzynski D., Ferreira-Dias G. Luteolysis and the auto-, paracrine role of cytokines from tumor necrosis factor &#x3b1; and transforming growth factor &#x3b2; superfamilies. Vitam Horm. . 2018;107:287&#x2013;315. doi: 10.1016/bs.vh.2018.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.vh.2018.01.001</ArticleId><ArticleId IdType="pubmed">29544635</ArticleId></ArticleIdList></Reference><Reference><Citation>Heider U., Pedal I., Spanel-Borowski K. Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries. Fertil Steril. . 2001;75(6):1141&#x2013;1147. doi: 10.1016/s0015-0282(01)01805-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0015-0282(01)01805-2</ArticleId><ArticleId IdType="pubmed">11384640</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna A., al Rifai A., Hubner B., Rother P., Spanel-Borowski K. Increase in calcitonin gene related peptide (CGRP) and decrease in mast cells in dihydroepiandrosterone (DHEA)-induced polycystic rat ovaries. Anat Embryol (Berl). . 2001;203(5):375&#x2013;382. doi: 10.1007/s004290100165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004290100165</ArticleId><ArticleId IdType="pubmed">11411312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H. M., Wu H. C., Sun Z. G., Lian F., Leung P. C. K. Neurotrophins and glial cell line-derived neurotrophic factor in the ovary: physiological and pathophysiological implications. Hum Reprod Update. . 2019;25(2):224&#x2013;242. doi: 10.1093/humupd/dmy047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humupd/dmy047</ArticleId><ArticleId IdType="pmc">PMC6390169</ArticleId><ArticleId IdType="pubmed">30608586</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J. K., Magistris A., Loizzi V., et al. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecol Oncol. . 2005;99(1):20&#x2013;25. doi: 10.1016/j.ygyno.2005.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2005.05.042</ArticleId><ArticleId IdType="pubmed">16055178</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldford S. A., Marshall J. S. Mast cells as targets for immunotherapy of solid tumors. Mol Immunol. . 2015;63(1):113&#x2013;124. doi: 10.1016/j.molimm.2014.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2014.02.020</ArticleId><ArticleId IdType="pubmed">24698842</ArticleId></ArticleIdList></Reference><Reference><Citation>Komi D. E. A., Redegeld F. A. Role of mast cells in shaping the tumor microenvironment. Clin Rev Allergy Immunol. . 2020;58(3):313&#x2013;325. doi: 10.1007/s12016-019-08753-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-019-08753-w</ArticleId><ArticleId IdType="pmc">PMC7244463</ArticleId><ArticleId IdType="pubmed">31256327</ArticleId></ArticleIdList></Reference><Reference><Citation>Glukhovets B. I., Ukhov I. I., Lebedev S. S. Tsiklicheskie izmeneniia tuchno-kletochno&#x12d; reaktsii i krovenosnykh kapilliarov v stenke matochnykh trub u zhenshchin [Cyclic changes in mast cell response and capillaries in the wall of the Fallopian tubes of women] Arkh Anat Gistol Embriol. . 1980;79(9):55&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">7436760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandvei R., Wollen A. L., Flood P. R., Anker C. Mast cells in the tubal wall in women using an intrauterine contraceptive device. Br J Obstet Gynaecol. . 1986;93(7):758&#x2013;764. doi: 10.1111/j.1471-0528.1986.tb07978.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.1986.tb07978.x</ArticleId><ArticleId IdType="pubmed">3730347</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral E., Olive D. L., Arici A. The peritoneal environment in endometriosis. Hum Reprod Update. . 1996;2(5):385&#x2013;398. doi: 10.1093/humupd/2.5.385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humupd/2.5.385</ArticleId><ArticleId IdType="pubmed">15717438</ArticleId></ArticleIdList></Reference><Reference><Citation>Broi M. G. D., Ferriani R. A., Navarro P. A. Ethiopathogenic mechanisms of endometriosis-related infertility. JBRA Assisted Reproduction . 2019;23(3):273&#x2013;280. doi: 10.5935/1518-0557.20190029.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/1518-0557.20190029</ArticleId><ArticleId IdType="pmc">PMC6724396</ArticleId><ArticleId IdType="pubmed">31091056</ArticleId></ArticleIdList></Reference><Reference><Citation>Borelli V., Martinelli M., Luppi S., et al. Mast cells in peritoneal fluid from women with endometriosis and their possible role in modulating sperm function. Front Physiol. . 2020;10:p. 1543. doi: 10.3389/fphys.2019.01543.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.01543</ArticleId><ArticleId IdType="pmc">PMC6964357</ArticleId><ArticleId IdType="pubmed">31998139</ArticleId></ArticleIdList></Reference><Reference><Citation>Drudy L., Sheppard B. L., Bonnar J. The ultrastructure of mast cells in the uterus throughout the normal menstrual cycle and the postmenopause. J Anat . 1991;14(1):p. 51. doi: 10.1016/0378-5122(91)90169-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-5122(91)90169-Q</ArticleId><ArticleId IdType="pmc">PMC1224469</ArticleId><ArticleId IdType="pubmed">2050575</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivridis E., Giatromanolaki A., Agnantis N., Anastasiadis P. Mast cell distribution and density in the normal uterus -- metachromatic staining using lectins. Eur J Obstet Gynecol Reprod Biol. . 2001;98(1):109&#x2013;113. doi: 10.1016/s0301-2115(00)00564-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0301-2115(00)00564-9</ArticleId><ArticleId IdType="pubmed">11516809</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jefout M., Black K., Schulke L., et al. Novel finding of high density of activated mast cells in endometrial polyps. Fertil Steril. . 2009;92(3):1104&#x2013;1106. doi: 10.1016/j.fertnstert.2009.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2009.02.016</ArticleId><ArticleId IdType="pubmed">19328474</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Hamarneh T., Hey-Cunningham A. J., Berbic M., Al-Jefout M., Fraser I. S., Black K. Cellular immune environment in endometrial polyps. Fertil Steril. . 2013;100(5):1364&#x2013;1372. doi: 10.1016/j.fertnstert.2013.06.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2013.06.050</ArticleId><ArticleId IdType="pubmed">23931965</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen F., Woudwyk M., Teles A., et al. Estradiol and progesterone regulate the migration of mast cells from the periphery to the uterus and induce their maturation and degranulation. PLoS One. . 2010;5(12, article e14409) doi: 10.1371/journal.pone.0014409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0014409</ArticleId><ArticleId IdType="pmc">PMC3008683</ArticleId><ArticleId IdType="pubmed">21203555</ArticleId></ArticleIdList></Reference><Reference><Citation>Elieh Ali Komi D., Shafaghat F., Haidl G. Significance of mast cells in spermatogenesis, implantation, pregnancy, and abortion: cross talk and molecular mechanisms. Am J Reprod Immunol . 2020;83(5):p. e13228. doi: 10.1111/aji.13228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aji.13228</ArticleId><ArticleId IdType="pubmed">32053232</ArticleId></ArticleIdList></Reference><Reference><Citation>Woidacki K., Zenclussen A. C., Siebenhaar F. Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome? Front Immunol. . 2014;5:p. 231. doi: 10.3389/fimmu.2014.00231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00231</ArticleId><ArticleId IdType="pmc">PMC4033021</ArticleId><ArticleId IdType="pubmed">24904581</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito H. Role of mast cell proteases in tissue remodeling. Chem Immunol Allergy. . 2005;87:80&#x2013;84. doi: 10.1159/000087572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000087572</ArticleId><ArticleId IdType="pubmed">16107764</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuno T., Toyoshima S., Sakamoto-Sasaki T., et al. Characterization of human decidual mast cells and establishment of a culture system. Allergol Int. . 2018;67:S18&#x2013;S24. doi: 10.1016/j.alit.2018.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2018.05.001</ArticleId><ArticleId IdType="pubmed">29784282</ArticleId></ArticleIdList></Reference><Reference><Citation>Derbala Y., Elazzamy H., Bilal M., et al. Mast cell-induced immunopathology in recurrent pregnancy losses. Am J Reprod Immunol. . 2019;82(1, article e13128) doi: 10.1111/aji.13128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aji.13128</ArticleId><ArticleId IdType="pubmed">31006153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueshima C., Kataoka T. R., Hirata M., et al. Possible involvement of human mast cells in the establishment of pregnancy via killer cell Ig-like receptor 2DL4. Am J Pathol. . 2018;188(6):1497&#x2013;1508. doi: 10.1016/j.ajpath.2018.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2018.02.012</ArticleId><ArticleId IdType="pubmed">29577936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka T. R., Ueshima C., Hirata M., Minamiguchi S., Haga H. Killer immunoglobulin-like receptor 2DL4 (CD158d) regulates human mast cells both positively and negatively: possible roles in pregnancy and cancer metastasis. Int J Mol Sci. . 2020;21(3):p. 954. doi: 10.3390/ijms21030954.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21030954</ArticleId><ArticleId IdType="pmc">PMC7037260</ArticleId><ArticleId IdType="pubmed">32023940</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczyk G., Szukiewicz D., Klimkiewicz J., Pyzlak M., Szewczyk A., Krajewska K. Influence of histamine on the process of human trophoblast differentiation. Inflamm Res. . 2005;54(Suppl 1):S78&#x2013;S79. doi: 10.1007/s00011-004-0436-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-004-0436-4</ArticleId><ArticleId IdType="pubmed">15928845</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin M., Zhu P., Luo H., Xu R. The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine devices. Contraception. . 1993;48(3):245&#x2013;254. doi: 10.1016/0010-7824(93)90143-u.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0010-7824(93)90143-u</ArticleId><ArticleId IdType="pubmed">8222654</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C. H., Chen S. U., Shun C. T., Tsao P. N., Yang Y. S., Yang J. H. Divergent endometrial inflammatory cytokine expression at peri-implantation period and after the stimulation by copper intrauterine device. Sci Rep. . 2015;5(1):p. 15157. doi: 10.1038/srep15157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15157</ArticleId><ArticleId IdType="pmc">PMC4606814</ArticleId><ArticleId IdType="pubmed">26469146</ArticleId></ArticleIdList></Reference><Reference><Citation>Garfield R. E., Irani A. M., Schwartz L. B., Bytautiene E., Romero R. Structural and functional comparison of mast cells in the pregnant versus nonpregnant human uterus. Am J Obstet Gynecol. . 2006;194(1):261&#x2013;267. doi: 10.1016/j.ajog.2005.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2005.05.011</ArticleId><ArticleId IdType="pubmed">16389041</ArticleId></ArticleIdList></Reference><Reference><Citation>Bytautiene E., Vedernikov Y. P., Saade G. R., Romero R., Garfield R. E. Degranulation of uterine mast cell modifies contractility of isolated myometrium from pregnant women. Am J Obstet Gynecol. . 2004;191(5):1705&#x2013;1710. doi: 10.1016/j.ajog.2004.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2004.04.008</ArticleId><ArticleId IdType="pubmed">15547545</ArticleId></ArticleIdList></Reference><Reference><Citation>Szukiewicz D., Maslinska D., Stelmach&#xf3;w J., Wojtecka-Lukasik E. Biogenetic amines in placental tissue. Relation to the contractile activity of the human uterus. Preliminary communication. Clin Exp Obstet Gynecol. . 1995;22(1):66&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">7736645</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitani R., Maeda K., Fukui R., et al. Production of human mast cell chymase in human myometrium and placenta in cases of normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol. . 2002;101(2):155&#x2013;160. doi: 10.1016/s0301-2115(01)00546-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0301-2115(01)00546-2</ArticleId><ArticleId IdType="pubmed">11858891</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Orl&#xe9;ans-Juste P., Houde M., Rae G. A., Bkaily G., Carrier E., Simard E. Endothelin-1 (1-31): from chymase-dependent synthesis to cardiovascular pathologies. Vascul Pharmacol. . 2008;49(2-3):51&#x2013;62. doi: 10.1016/j.vph.2008.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2008.06.007</ArticleId><ArticleId IdType="pubmed">18675382</ArticleId></ArticleIdList></Reference><Reference><Citation>Norstr&#xf6;m A., Vukas Radulovic N., Bullarbo M., Ekerhovd E. Mast cell involvement in human cervical ripening. Eur J Obstet Gynecol Reprod Biol. . 2019;238:157&#x2013;163. doi: 10.1016/j.ejogrb.2019.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2019.05.010</ArticleId><ArticleId IdType="pubmed">31158573</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurihara-Shimomura M., Sasahira T., Shimomura H., Bosserhoff A. K., Kirita T. Mast cell chymase promotes angiogenesis and lymphangiogenesis mediated by activation of melanoma inhibitory activity gene family members in oral squamous cell carcinoma. Int J Oncol. . 2020;56(5):1093&#x2013;1100. doi: 10.3892/ijo.2020.4996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2020.4996</ArticleId><ArticleId IdType="pubmed">32319583</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza D. A., Borges A. C., Santana A. C., Oliver C., Jamur M. C. Mast cell proteases 6 and 7 stimulate angiogenesis by inducing endothelial cells to release angiogenic factors. PLoS One. . 2015;10(12, article e0144081) doi: 10.1371/journal.pone.0144081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0144081</ArticleId><ArticleId IdType="pmc">PMC4669151</ArticleId><ArticleId IdType="pubmed">26633538</ArticleId></ArticleIdList></Reference><Reference><Citation>Szukiewicz D., Szukiewicz A., Maslinska D., Poppe P., Gujski M., Olszewski M. Mast cells and histamine in intrauterine growth retardation--relation to the development of placental microvessels. Inflamm Res. . 1999;48(1):41&#x2013;42. doi: 10.1007/s000110050392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000110050392</ArticleId><ArticleId IdType="pubmed">10350154</ArticleId></ArticleIdList></Reference><Reference><Citation>Szukiewicz D., Szukiewicz A., Maslinska D., Szewczyk G., Watroba M. Mast cell-derived vascular endothelial growth factor (VEGF) and microvascular density in diabetic placentae. Inflamm Res. . 2003;52:s9&#x2013;10. doi: 10.1007/s000110300030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000110300030</ArticleId><ArticleId IdType="pubmed">12755387</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczyk G., Ma&#x15b;li&#x144;ska D., Szukiewicz D., &#x15a;miertka W., Klimkiewicz J., Pyzlak M. Histamine H4 receptors in human placenta in diabetes-complicated pregnancy. Inflamm Res. . 2007;56(Suppl 1):S31&#x2013;S32. doi: 10.1007/s00011-006-0515-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-006-0515-9</ArticleId><ArticleId IdType="pubmed">17806168</ArticleId></ArticleIdList></Reference><Reference><Citation>Faas M. M., De Vos P. Innate immune cells in the placental bed in healthy pregnancy and preeclampsia. Placenta. . 2018;69:125&#x2013;133. doi: 10.1016/j.placenta.2018.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2018.04.012</ArticleId><ArticleId IdType="pubmed">29748088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Alexander J. S. Role of chymase in preeclampsia. Curr Vasc Pharmacol. . 2013;11(5):606&#x2013;615. doi: 10.2174/1570161111311050005.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570161111311050005</ArticleId><ArticleId IdType="pubmed">24063379</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczyk G., Pyzlak M., Klimkiewicz J., Smiertka W., Miedzi&#x144;ska-Maciejewska M., Szukiewicz D. Mast cells and histamine: do they influence placental vascular network and development in preeclampsia? Mediators Inflamm. . 2012;2012, article 307189:5. doi: 10.1155/2012/307189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/307189</ArticleId><ArticleId IdType="pmc">PMC3388381</ArticleId><ArticleId IdType="pubmed">22778495</ArticleId></ArticleIdList></Reference><Reference><Citation>Szukiewicz D., Szukiewicz A., Maslinska D., Gujski M., Poppe P., Mazurek-Kantor J. Mast cell number, histamine concentration and placental vascular response to histamine in preeclampsia. Inflamm Res. . 1999;48:39&#x2013;40. doi: 10.1007/s000110050390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000110050390</ArticleId><ArticleId IdType="pubmed">10350153</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczyk G., Pyzlak M., Smiertka W., Klimkiewicz J., Szukiewicz D. Does histamine influence differentiation of trophoblast in preeclampsia? Inflamm Res. . 2008;57(Suppl 1):71&#x2013;72. doi: 10.1007/s00011-007-0635-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-007-0635-x</ArticleId><ArticleId IdType="pubmed">18345483</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer N., Woidacki K., Kn&#xf6;fler M., et al. Chymase-producing cells of the innate immune system are required for decidual vascular remodeling and fetal growth. Sci Rep. . 2017;7(1):p. 45106. doi: 10.1038/srep45106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep45106</ArticleId><ArticleId IdType="pmc">PMC5361184</ArticleId><ArticleId IdType="pubmed">28327604</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z. M., Yang H., Li M., et al. Pro-inflammatory cytokine-stimulated first trimester decidual cells enhance macrophage-induced apoptosis of extravillous trophoblasts. Placenta. . 2012;33(3):188&#x2013;194. doi: 10.1016/j.placenta.2011.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2011.12.007</ArticleId><ArticleId IdType="pmc">PMC3406179</ArticleId><ArticleId IdType="pubmed">22212249</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyzlak M., Szewczyk G., Szukiewicz D., Szczesniak A. Histamine influence on apoptosis in trophoblast cell cultures. Inflamm Res. . 2010;59(Suppl 2):S213&#x2013;S215. doi: 10.1007/s00011-009-0133-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-009-0133-4</ArticleId><ArticleId IdType="pubmed">20091086</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Kilburn B. A., Leach R. E., Romero R., Paria B. C., Armant D. R. Histamine enhances cytotrophoblast invasion by inducing intracellular calcium transients through the histamine type-1 receptor. Mol Reprod Dev. . 2004;68(3):345&#x2013;353. doi: 10.1002/mrd.20082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrd.20082</ArticleId><ArticleId IdType="pubmed">15112328</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham K., Fadia M., Dahlstrom J. E., Harrington K., Shadbolt B., Robson S. Significance of mast cell distribution in placental tissue and membranes in spontaneous preterm birth. J Inflamm Res. . 2016;Volume 9:141&#x2013;145. doi: 10.2147/JIR.S80722.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S80722</ArticleId><ArticleId IdType="pmc">PMC4944924</ArticleId><ArticleId IdType="pubmed">27468246</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelius M. S., Enke U., Varosi F., et al. Placental immune response to apple allergen in allergic mothers. J Reprod Immunol. . 2014;106:100&#x2013;109. doi: 10.1016/j.jri.2014.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jri.2014.05.001</ArticleId><ArticleId IdType="pubmed">25048667</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen A. L., Felding C., Larsen L. G., Andersen B., Sander P. Mast cells in the placenta. Is there a relation to the development of atopic disease in infants before 18 months of age? J Perinat Med. . 1994;22(4):273&#x2013;278. doi: 10.1515/jpme.1994.22.4.273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jpme.1994.22.4.273</ArticleId><ArticleId IdType="pubmed">7877063</ArticleId></ArticleIdList></Reference><Reference><Citation>Straubinger K., Paul S., Prazeres da Costa O., et al. Maternal immune response to helminth infection during pregnancy determines offspring susceptibility to allergic airway inflammation. J Allergy Clin Immunol . 2014;134(6):1271&#x2013;1279.e10. doi: 10.1016/j.jaci.2014.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.05.034</ArticleId><ArticleId IdType="pubmed">25042744</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadogiannakis N., Joerink M., Rindsj&#xf6; E., Scheynius A., Alm J. Placental inflammation, lifestyle, maternal and early child sensitisation to allergens - the assessment of lifestyle and allergic disease during infancy birth cohort. Acta Paediatr. . 2019;108(5):927&#x2013;932. doi: 10.1111/apa.14618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.14618</ArticleId><ArticleId IdType="pubmed">30338564</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaf V., Chapron C., El Nakadi I., De Moor V., Simonart T., No&#xeb;l J. C. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertil Steril. . 2006;86(5):1336&#x2013;1343. doi: 10.1016/j.fertnstert.2006.03.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2006.03.057</ArticleId><ArticleId IdType="pubmed">17007852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu T. H., Zou G., Ding S. J., et al. Mast cell stabilizer ketotifen reduces hyperalgesia in a rodent model of surgically induced endometriosis. J Pain Res. . 2019;12:1359&#x2013;1369. doi: 10.2147/JPR.S195909.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S195909</ArticleId><ArticleId IdType="pmc">PMC6500880</ArticleId><ArticleId IdType="pubmed">31118754</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Cruz O. J., Uckun F. M. Targeting mast cells in endometriosis with Janus kinase 3 inhibitor, JANEX-1. Am J Reprod Immunol. . 2007;58(2):75&#x2013;97. doi: 10.1111/j.1600-0897.2007.00502.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0897.2007.00502.x</ArticleId><ArticleId IdType="pubmed">17631002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu T. H., Ding S. J., Li T. T., Zhu L. B., Huang X. F., Zhang X. M. Estrogen is an important mediator of mast cell activation in ovarian endometriomas. Reproduction. . 2018;155(1):73&#x2013;83. doi: 10.1530/REP-17-0457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/REP-17-0457</ArticleId><ArticleId IdType="pubmed">29074615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchhoff D., Kaulfuss S., Fuhrmann U., Maurer M., Zollner T. M. Mast cells in endometriosis: guilty or innocent bystanders? Expert Opin Ther Targets. . 2012;16(3):237&#x2013;241. doi: 10.1517/14728222.2012.661415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.2012.661415</ArticleId><ArticleId IdType="pubmed">22332753</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Papadopoulou N., Stanford E. J., et al. Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin. Am J Reprod Immunol. . 2004;52(4):267&#x2013;275. doi: 10.1111/j.1600-0897.2004.00224.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0897.2004.00224.x</ArticleId><ArticleId IdType="pubmed">15494048</ArticleId></ArticleIdList></Reference><Reference><Citation>Norrby K. Evidence of a dual role of endogenous histamine in angiogenesis. Int J Exp Pathol. . 1995;76(2):87&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1997159</ArticleId><ArticleId IdType="pubmed">7540412</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue S., Tang H., Zhao G., et al. C-C Motif Chemokine 8 promotes angiogenesis in vascular endothelial cells. Vascular. . 2021;29(3):429&#x2013;441. doi: 10.1177/1708538120959972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1708538120959972</ArticleId><ArticleId IdType="pubmed">32972333</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Wang J., Guo X., et al. Possible involvement of crosstalk between endometrial cells and mast cells in the development of endometriosis via CCL8/CCR1. Biomed Pharmacother. . 2020;129:p. 110476. doi: 10.1016/j.biopha.2020.110476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110476</ArticleId><ArticleId IdType="pubmed">32768961</ArticleId></ArticleIdList></Reference><Reference><Citation>Binda M. M., Donnez J., Dolmans M. M. Targeting mast cells: a new way to treat endometriosis. Expert Opin Ther Targets. . 2017;21(1):67&#x2013;75. doi: 10.1080/14728222.2017.1260548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2017.1260548</ArticleId><ArticleId IdType="pubmed">27841046</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T. C. Neuroendocrinology of mast cells: challenges and controversies. Exp Dermatol. . 2017;26(9):751&#x2013;759. doi: 10.1111/exd.13288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exd.13288</ArticleId><ArticleId IdType="pubmed">28094875</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Xu X., Li T., et al. NLRP3 inflammasome activation of mast cells by estrogen via the nuclear-initiated signaling pathway contributes to the development of endometriosis. Front Immunol. . 2021;12:p. 749979. doi: 10.3389/fimmu.2021.749979.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.749979</ArticleId><ArticleId IdType="pmc">PMC8494307</ArticleId><ArticleId IdType="pubmed">34630429</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal K., Krishna A. Effects of hormones on the number, distribution and degranulation of mast cells in the ovarian complex of mice. Acta Physiol Hung. . 1996;84(2):183&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">9046364</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt G., Owman C., Sj&#xf6;berg N. O. Cellular localization of ovarian histamine, its cyclic variations, and histaminergic effects on ovulation in the rat ovary perfused in vitro. Reproduction . 1988;82(2):409&#x2013;417. doi: 10.1530/jrf.0.0820409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/jrf.0.0820409</ArticleId><ArticleId IdType="pubmed">3361478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamouzova P., Cizek P., Bartoskova A., Vitasek R., Tichy F. Changes in the mast cell distribution in the canine ovary and uterus throughout the oestrous cycle. Reprod Domest Anim. . 2020;55(4):479&#x2013;485. doi: 10.1111/rda.13641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/rda.13641</ArticleId><ArticleId IdType="pubmed">31961006</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher A., Sharkey D. J., Robertson S. A., Zenclussen A. C. Immune cells at the fetomaternal interface: how the microenvironment modulates immune cells to foster fetal development. J Immunol. . 2018;201(2):325&#x2013;334. doi: 10.4049/jimmunol.1800058.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800058</ArticleId><ArticleId IdType="pubmed">29987001</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall J. S., Portales-Cervantes L., Leong E. Mast cell responses to viruses and pathogen products. Int J Mol Sci. . 2019;20(17):p. 4241. doi: 10.3390/ijms20174241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20174241</ArticleId><ArticleId IdType="pmc">PMC6747121</ArticleId><ArticleId IdType="pubmed">31480219</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti G., Giannitto N., De Luca F. L., et al. Kawasaki disease and cardiac involvement: an update on the state of the art. J Biol Regul Homeost Agents . 2020;34:1629&#x2013;1632. doi: 10.23812/20-2EDIT.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-2EDIT</ArticleId><ArticleId IdType="pubmed">33000600</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham S. N., St John A. L. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol. . 2010;10(6):440&#x2013;452. doi: 10.1038/nri2782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2782</ArticleId><ArticleId IdType="pmc">PMC4469150</ArticleId><ArticleId IdType="pubmed">20498670</ArticleId></ArticleIdList></Reference><Reference><Citation>Galli S. J., Gaudenzio N., Tsai M. Mast cells in inflammation and disease: recent progress and ongoing concerns. Annu Rev Immunol. . 2020;38:49&#x2013;77. doi: 10.1146/annurev-immunol-071719-094903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-071719-094903</ArticleId><ArticleId IdType="pubmed">32340580</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver R. B., Reid A. C., Mackins C. J., et al. Mast cells: a unique source of renin. Proc Natl Acad Sci U S A. . 2004;101(37):13607&#x2013;13612. doi: 10.1073/pnas.0403208101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0403208101</ArticleId><ArticleId IdType="pmc">PMC518801</ArticleId><ArticleId IdType="pubmed">15342908</ArticleId></ArticleIdList></Reference><Reference><Citation>Maaninka K., Nguyen S. D., M&#xe4;yr&#xe4;np&#xe4;&#xe4; M. I., et al. Human mast cell neutral proteases generate modified LDL particles with increased proteoglycan binding. Atherosclerosis. . 2018;275:390&#x2013;399. doi: 10.1016/j.atherosclerosis.2018.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2018.04.016</ArticleId><ArticleId IdType="pubmed">29703634</ArticleId></ArticleIdList></Reference><Reference><Citation>Heutinck K. M., ten Berge I. J., Hack C. E., Hamann J., Rowshani A. T. Serine proteases of the human immune system in health and disease. Mol Immunol. . 2010;47(11-12):1943&#x2013;1955. doi: 10.1016/j.molimm.2010.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2010.04.020</ArticleId><ArticleId IdType="pubmed">20537709</ArticleId></ArticleIdList></Reference><Reference><Citation>Peljer G., Abrink M., Ringvall M., Wernersson S. Mast cell proteases. Adv Immunol. . 2007;95:167&#x2013;255. doi: 10.1016/S0065-2776(07)95006-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-2776(07)95006-3</ArticleId><ArticleId IdType="pubmed">17869614</ArticleId></ArticleIdList></Reference><Reference><Citation>Peljer G., Ronnberg E., Waern I., Wernersson S. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood. . 2010;115(24):4981&#x2013;4990. doi: 10.1182/blood-2010-01-257287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-01-257287</ArticleId><ArticleId IdType="pubmed">20233968</ArticleId></ArticleIdList></Reference><Reference><Citation>Caughey G. H. Mast cell proteases as pharmacological targets. Eur J Pharmacol. . 2016;778:44&#x2013;55. doi: 10.1016/j.ejphar.2015.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2015.04.045</ArticleId><ArticleId IdType="pmc">PMC4636979</ArticleId><ArticleId IdType="pubmed">25958181</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Sj&#xf6;berg S., Tang T. T., et al. Cathepsin G activity lowers plasma LDL and reduces atherosclerosis. Biochim Biophys Acta. . 2014;1842(11):2174&#x2013;2183. doi: 10.1016/j.bbadis.2014.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.07.026</ArticleId><ArticleId IdType="pmc">PMC4188792</ArticleId><ArticleId IdType="pubmed">25092171</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiligada E., Ennis M. Histamine pharmacology: from Sir Henry Dale to the 21st century. Br J Pharmacol. . 2020;177(3):469&#x2013;489. doi: 10.1111/bph.14524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14524</ArticleId><ArticleId IdType="pmc">PMC7012941</ArticleId><ArticleId IdType="pubmed">30341770</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter M., Stark H. Histamine receptor subtypes: a century of rational drug design. Front Biosci . 2012;S4(2):461&#x2013;488. doi: 10.2741/s279.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/s279</ArticleId><ArticleId IdType="pubmed">22202071</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangam E. B., Jemima E. A., Singh H., et al. The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: the hunt for new therapeutic targets. Front Immunol. . 2018;9:p. 1873. doi: 10.3389/fimmu.2018.01873.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01873</ArticleId><ArticleId IdType="pmc">PMC6099187</ArticleId><ArticleId IdType="pubmed">30150993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattori Y., Hattori K., Matsuda N. Regulation of the cardiovascular system by histamine. Handb Exp Pharmacol. . 2017;241:239&#x2013;258. doi: 10.1007/164_2016_15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/164_2016_15</ArticleId><ArticleId IdType="pubmed">27838850</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnin A., Levitt P. Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience. . 2011;197:1&#x2013;7. doi: 10.1016/j.neuroscience.2011.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.10.005</ArticleId><ArticleId IdType="pmc">PMC3225275</ArticleId><ArticleId IdType="pubmed">22001683</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzil S., Walker D. W., Borg A. J., Wallace E. M., Ebeling P. R., Murthi P. The relationship between the placental serotonin pathway and fetal growth restriction. Biochimie. . 2019;161:80&#x2013;87. doi: 10.1016/j.biochi.2018.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2018.12.016</ArticleId><ArticleId IdType="pubmed">30605696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushnir-Sukhov N. M., Brown J. M., Wu Y., Kirshenbaum A., Metcalfe D. D. Human mast cells are capable of serotonin synthesis and release. J Allergy Clin Immunol. . 2007;119(2):498&#x2013;499. doi: 10.1016/j.jaci.2006.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2006.09.003</ArticleId><ArticleId IdType="pubmed">17291861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritter M., El-Nour H., Hedblad M. A., et al. Serotonin and its 5-HT1 receptor in human mastocytosis. Immunopharmacol Immunotoxicol. . 2012;34(4):679&#x2013;685. doi: 10.3109/08923973.2011.651222.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08923973.2011.651222</ArticleId><ArticleId IdType="pubmed">22268664</ArticleId></ArticleIdList></Reference><Reference><Citation>Nautiyal K. M., Dailey C. A., Jahn J. L., et al. Serotonin of mast cell origin contributes to hippocampal function. Eur J Neurosci. . 2012;36(3):2347&#x2013;2359. doi: 10.1111/j.1460-9568.2012.08138.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2012.08138.x</ArticleId><ArticleId IdType="pmc">PMC3721752</ArticleId><ArticleId IdType="pubmed">22632453</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;nnberg E., Melo F. R., Pejler G. Mast cell proteoglycans. J Histochem Cytochem. . 2012;60(12):950&#x2013;962. doi: 10.1369/0022155412458927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155412458927</ArticleId><ArticleId IdType="pmc">PMC3527880</ArticleId><ArticleId IdType="pubmed">22899859</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulloy B., Lever R., Page C. P. Mast cell glycosaminoglycans. Glycoconj J. . 2017;34(3):351&#x2013;361. doi: 10.1007/s10719-016-9749-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10719-016-9749-0</ArticleId><ArticleId IdType="pmc">PMC5487770</ArticleId><ArticleId IdType="pubmed">27900574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zehnder J. L., Galli S. J. Mast-cell heparin demystified. Nature. . 1999;400(6746):714&#x2013;715. doi: 10.1038/23360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/23360</ArticleId><ArticleId IdType="pubmed">10466718</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahid M. N. A., Kiyoi T. Mast cell activation markers for in vitro study. J Immunoassay Immunochem. . 2020;41(4):778&#x2013;816. doi: 10.1080/15321819.2020.1769129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15321819.2020.1769129</ArticleId><ArticleId IdType="pubmed">32501748</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Yang J., Luo W., et al. Prostaglandin D2 is the major cyclooxygenase-1-derived product in prepartum mouse uteri where it mediates an enhanced in vitro myometrial contraction. Eur J Pharmacol. . 2017;813:140&#x2013;146. doi: 10.1016/j.ejphar.2017.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2017.08.015</ArticleId><ArticleId IdType="pubmed">28822852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T., Murata T. Regulation of vascular permeability in anaphylaxis. Br J Pharmacol. . 2018;175(13):2538&#x2013;2542. doi: 10.1111/bph.14332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14332</ArticleId><ArticleId IdType="pmc">PMC6003654</ArticleId><ArticleId IdType="pubmed">29671869</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T. C., Alysandratos K. D., Angelidou A., et al. Mast cells and inflammation. Biochim Biophys Acta. . 2012;1822(1):21&#x2013;33. doi: 10.1016/j.bbadis.2010.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2010.12.014</ArticleId><ArticleId IdType="pmc">PMC3318920</ArticleId><ArticleId IdType="pubmed">21185371</ArticleId></ArticleIdList></Reference><Reference><Citation>Elieh Ali Komi D., W&#xf6;hrl S., Bielory L. Mast cell biology at molecular level: a comprehensive review. Clin Rev Allergy Immunol. . 2020;58(3):342&#x2013;365. doi: 10.1007/s12016-019-08769-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-019-08769-2</ArticleId><ArticleId IdType="pubmed">31828527</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon T. C., Befus A. D., Kulka M. Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol. . 2014;5:p. 569. doi: 10.3389/fimmu.2014.00569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00569</ArticleId><ArticleId IdType="pmc">PMC4231949</ArticleId><ArticleId IdType="pubmed">25452755</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon T. C., St Laurent C. D., Morris K. E., et al. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol . 2010;3(2):111&#x2013;128. doi: 10.1038/mi.2009.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2009.136</ArticleId><ArticleId IdType="pubmed">20043008</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibilano R., Frossi B., Pucillo C. E. Mast cell activation: a complex interplay of positive and negative signaling pathways. Eur J Immunol. . 2014;44(9):2558&#x2013;2566. doi: 10.1002/eji.201444546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201444546</ArticleId><ArticleId IdType="pubmed">25066089</ArticleId></ArticleIdList></Reference><Reference><Citation>Tkaczyk C., Iwaki S., Metcalfe D. D., Gilfillan A. M. Roles of adaptor molecules in mast cell activation. Chem Immunol Allergy. . 2005;87:43&#x2013;58. doi: 10.1159/000087570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000087570</ArticleId><ArticleId IdType="pubmed">16107762</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishizaka T., White J. R., Saito H. Activation of basophils and mast cells for mediator release. Int Arch Allergy Appl Immunol. . 1987;82(3-4):327&#x2013;332. doi: 10.1159/000234218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000234218</ArticleId><ArticleId IdType="pubmed">3106238</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhang L., Joo D., Sun S. C. NF-&#x3ba;B signaling in inflammation. Signal Transduct Target Ther . 2017;2:p. 17023. doi: 10.1038/sigtrans.2017.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbu E. A., Zhang J., Berenstein E. H., Groves J. R., Parks L. M., Siraganian R. P. The transcription factor Zeb2 regulates signaling in mast cells. J Immunol. . 2012;188(12):6278&#x2013;6286. doi: 10.4049/jimmunol.1102660.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102660</ArticleId><ArticleId IdType="pmc">PMC3370126</ArticleId><ArticleId IdType="pubmed">22561153</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M. S., Kuehn H. S., Metcalfe D. D., Gilfillan A. M. Activation and function of the mTORC1 pathway in mast cells. J Immunol. . 2008;180(7):4586&#x2013;4595. doi: 10.4049/jimmunol.180.7.4586.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.7.4586</ArticleId><ArticleId IdType="pmc">PMC2698706</ArticleId><ArticleId IdType="pubmed">18354181</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan P. L., Sabat&#xe9;-Bresc&#xf3; M., Guo Y., Mart&#xed;n M., Gastaminza G. The multifaceted Mas-related G protein-coupled receptor member X2 in allergic diseases and beyond. Int J Mol Sci. . 2021;22(9):p. 4421. doi: 10.3390/ijms22094421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094421</ArticleId><ArticleId IdType="pmc">PMC8122879</ArticleId><ArticleId IdType="pubmed">33922606</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank U., Huang H., Kawakami T. The high affinity IgE receptor: a signaling update. Curr Opin Immunol. . 2021;72:51&#x2013;58. doi: 10.1016/j.coi.2021.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2021.03.015</ArticleId><ArticleId IdType="pubmed">33838574</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons D. O., Pullen N. A. Beyond IgE: alternative mast cell activation across different disease states. Int J Mol Sci. . 2020;21(4):p. 1498. doi: 10.3390/ijms21041498.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041498</ArticleId><ArticleId IdType="pmc">PMC7073060</ArticleId><ArticleId IdType="pubmed">32098318</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Sun P. D. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity. J Biol Chem. . 2020;295(52):18579&#x2013;18588. doi: 10.1074/jbc.RA120.015303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.015303</ArticleId><ArticleId IdType="pmc">PMC7833600</ArticleId><ArticleId IdType="pubmed">33122196</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Xiang R., Huo S., et al. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct Target Ther. . 2021;6(1):p. 233. doi: 10.1038/s41392-021-00653-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00653-w</ArticleId><ArticleId IdType="pmc">PMC8193598</ArticleId><ArticleId IdType="pubmed">34117216</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T. C. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. Biofactors. . 2020;46(3):306&#x2013;308. doi: 10.1002/biof.1633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1633</ArticleId><ArticleId IdType="pmc">PMC7267424</ArticleId><ArticleId IdType="pubmed">32339387</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T. C. Potential association of mast cells with coronavirus disease 2019. Ann Allergy Asthma Immunol. . 2021;126(3):217&#x2013;218. doi: 10.1016/j.anai.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7644430</ArticleId><ArticleId IdType="pubmed">33161155</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanczak M. A., Sanin D. E., Apostolova P., et al. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals. Nat Commun. . 2021;12(1):p. 2133. doi: 10.1038/s41467-021-22449-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22449-w</ArticleId><ArticleId IdType="pmc">PMC8035172</ArticleId><ArticleId IdType="pubmed">33837219</ArticleId></ArticleIdList></Reference><Reference><Citation>West P. W., Bahri R., Garcia-Rodriguez K. M., et al. Interleukin-33 amplifies human mast cell activities induced by complement anaphylatoxins. Front Immunol. . 2021;11:p. 615236. doi: 10.3389/fimmu.2020.615236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.615236</ArticleId><ArticleId IdType="pmc">PMC7882629</ArticleId><ArticleId IdType="pubmed">33597949</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T. C. The impact of psychological stress on mast cells. Ann Allergy Asthma Immunol. . 2020;125(4):388&#x2013;392. doi: 10.1016/j.anai.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.07.007</ArticleId><ArticleId IdType="pubmed">32687989</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfia G., Navone S., Guarnaccia L., et al. Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19. EMBO Mol Med . 2021;13(1, article e13424) doi: 10.15252/emmm.202013424.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013424</ArticleId><ArticleId IdType="pmc">PMC7744841</ArticleId><ArticleId IdType="pubmed">33190411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ennis M., Tiligada K. Histamine receptors and COVID-19. Inflamm Res. . 2021;70(1):67&#x2013;75. doi: 10.1007/s00011-020-01422-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01422-1</ArticleId><ArticleId IdType="pmc">PMC7673069</ArticleId><ArticleId IdType="pubmed">33206207</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hasani R., Bruchas M. R. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. . 2011;115(6):1363&#x2013;1381. doi: 10.1097/ALN.0b013e318238bba6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318238bba6</ArticleId><ArticleId IdType="pmc">PMC3698859</ArticleId><ArticleId IdType="pubmed">22020140</ArticleId></ArticleIdList></Reference><Reference><Citation>Barke K. E., Hough L. B. Opiates, mast cells and histamine release. Life Sci. . 1993;53(18):1391&#x2013;1399. doi: 10.1016/0024-3205(93)90581-m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(93)90581-m</ArticleId><ArticleId IdType="pubmed">7694026</ArticleId></ArticleIdList></Reference><Reference><Citation>Han N. R., Oh H. A., Nam S. Y., et al. TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6. J Invest Dermatol. . 2014;134(10):2521&#x2013;2530. doi: 10.1038/jid.2014.198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2014.198</ArticleId><ArticleId IdType="pubmed">24751726</ArticleId></ArticleIdList></Reference><Reference><Citation>Demopoulos C., Antonopoulou S., Theoharides T. C. COVID-19, microthromboses, inflammation, and platelet activating factor. Biofactors. . 2020;46(6):927&#x2013;933. doi: 10.1002/biof.1696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1696</ArticleId><ArticleId IdType="pubmed">33296106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi Y. N., Ping N. N., Cao Y. X. Ligands and signaling of Mas-related G protein-coupled receptor-X2 in mast cell activation. Rev Physiol Biochem Pharmacol. . 2021;179:139&#x2013;188. doi: 10.1007/112_2020_53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/112_2020_53</ArticleId><ArticleId IdType="pubmed">33479839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam H. Y., Tergaonkar V., Kumar A. P., Ahn K. S. Mast cells: therapeutic targets for COVID-19 and beyond. IUBMB Life. . 2021;73(11):1278&#x2013;1292. doi: 10.1002/iub.2552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2552</ArticleId><ArticleId IdType="pmc">PMC8652840</ArticleId><ArticleId IdType="pubmed">34467628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandig H., Bulfone-Paus S. TLR signaling in mast cells: common and unique features. Front Immunol. . 2012;3:p. 185. doi: 10.3389/fimmu.2012.00185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00185</ArticleId><ArticleId IdType="pmc">PMC3389341</ArticleId><ArticleId IdType="pubmed">22783258</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B. A., Elemam N. M., Maghazachi A. A. Chemokines and chemokine receptors during COVID-19 infection. Comput Struct Biotechnol J. . 2021;19:976&#x2013;988. doi: 10.1016/j.csbj.2021.01.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.01.034</ArticleId><ArticleId IdType="pmc">PMC7859556</ArticleId><ArticleId IdType="pubmed">33558827</ArticleId></ArticleIdList></Reference><Reference><Citation>Juremalm M., Nilsson G. Chemokine receptor expression by mast cells. Chem Immunol Allergy. . 2005;87:130&#x2013;144. doi: 10.1159/000087640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000087640</ArticleId><ArticleId IdType="pubmed">16107768</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Jubair S., Levick S. P., Janicki J. S. The autocrine role of tryptase in pressure overload-induced mast cell activation, chymase release and cardiac fibrosis. IJC Metab Endocr. . 2016;10:16&#x2013;23. doi: 10.1016/j.ijcme.2015.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcme.2015.11.003</ArticleId><ArticleId IdType="pmc">PMC4692252</ArticleId><ArticleId IdType="pubmed">26722642</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer H. S., Kelso E. B., Lockhart J. C., et al. Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells. Arthritis Rheum. . 2007;56(11):3532&#x2013;3540. doi: 10.1002/art.22936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22936</ArticleId><ArticleId IdType="pubmed">17968878</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagashima S., Dutra A. A., Arantes M. P., et al. COVID-19 and lung mast cells: the Kallikrein-Kinin activation pathway. Int J Mol Sci . 2022;23(3):p. 1714. doi: 10.3390/ijms23031714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031714</ArticleId><ArticleId IdType="pmc">PMC8836064</ArticleId><ArticleId IdType="pubmed">35163636</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam S., Ruf W., Bosmann M. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019. Br J Pharmacol. . 2022;179(10):2086&#x2013;2099. doi: 10.1111/bph.15587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15587</ArticleId><ArticleId IdType="pmc">PMC8794588</ArticleId><ArticleId IdType="pubmed">34235728</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z. G., Wei Q., Jayasekara M. P., Jacobson K. A. The role of P2Y(14) and other P2Y receptors in degranulation of human LAD2 mast cells. Purinergic Signal. . 2013;9(1):31&#x2013;40. doi: 10.1007/s11302-012-9325-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-012-9325-4</ArticleId><ArticleId IdType="pmc">PMC3568423</ArticleId><ArticleId IdType="pubmed">22825617</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z. G., Jacobson K. A. Purinergic signaling in mast cell degranulation and asthma. Front Pharmacol. . 2017;8:p. 947. doi: 10.3389/fphar.2017.00947.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00947</ArticleId><ArticleId IdType="pmc">PMC5744008</ArticleId><ArticleId IdType="pubmed">29311944</ArticleId></ArticleIdList></Reference><Reference><Citation>Franciosi M. L. M., Lima M. D. M., Schetinger M. R. C., Cardoso A. M. Possible role of purinergic signaling in COVID-19. Mol Cell Biochem. . 2021;476(8):2891&#x2013;2898. doi: 10.1007/s11010-021-04130-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-021-04130-4</ArticleId><ArticleId IdType="pmc">PMC7973800</ArticleId><ArticleId IdType="pubmed">33740184</ArticleId></ArticleIdList></Reference><Reference><Citation>McArdel S. L., Terhorst C., Sharpe A. H. Roles of CD48 in regulating immunity and tolerance. Clin Immunol. . 2016;164:10&#x2013;20. doi: 10.1016/j.clim.2016.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.01.008</ArticleId><ArticleId IdType="pmc">PMC4860950</ArticleId><ArticleId IdType="pubmed">26794910</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelombitko M. A., Fedorov A. V., Ilyinskaya O. P., Zinovkin R. A., Chernyak B. V. Role of reactive oxygen species in mast cell degranulation. Biochemistry (Mosc). . 2016;81(12):1564&#x2013;1577. doi: 10.1134/S000629791612018X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S000629791612018X</ArticleId><ArticleId IdType="pubmed">28259134</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnez J., Binda M. M., Donnez O., Dolmans M. M. Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis. Fertil Steril. . 2016;106(5):1011&#x2013;1017. doi: 10.1016/j.fertnstert.2016.07.1075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2016.07.1075</ArticleId><ArticleId IdType="pubmed">27521769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zal F., Khademi F., Taheri R., Mostafavi-Pour Z. Antioxidant ameliorating effects against H2O2-induced cytotoxicity in primary endometrial cells. Toxicol Mech Methods. . 2018;28(2):122&#x2013;129. doi: 10.1080/15376516.2017.1372540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15376516.2017.1372540</ArticleId><ArticleId IdType="pubmed">28849685</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini A., Bruno C., Vergani E., d&#x2019;Abate C., Giacchi E., Silvestrini A. Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights. Int J Mol Sci. . 2021;22(4):p. 1667. doi: 10.3390/ijms22041667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041667</ArticleId><ArticleId IdType="pmc">PMC7915804</ArticleId><ArticleId IdType="pubmed">33562271</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardet J. C., Castells M. C., Hamilton M. J. Immunology and clinical manifestations of non-clonal mast cell activation syndrome. Curr Allergy Asthma Rep. . 2013;13(1):10&#x2013;18. doi: 10.1007/s11882-012-0326-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-012-0326-8</ArticleId><ArticleId IdType="pmc">PMC3545645</ArticleId><ArticleId IdType="pubmed">23212667</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannetti A., Filice E., Caffarelli C., Ricci G., Pession A. Mast cell activation disorders. Medicina (Kaunas). . 2021;57(2):p. 124. doi: 10.3390/medicina57020124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57020124</ArticleId><ArticleId IdType="pmc">PMC7911219</ArticleId><ArticleId IdType="pubmed">33573161</ArticleId></ArticleIdList></Reference><Reference><Citation>Petra A. I., Panagiotidou S., Stewart J. M., Conti P., Theoharides T. C. Spectrum of mast cell activation disorders. Expert Rev Clin Immunol. . 2014;10(6):729&#x2013;739. doi: 10.1586/1744666X.2014.906302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/1744666X.2014.906302</ArticleId><ArticleId IdType="pubmed">24784142</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterfield J. H., Ravi A., Pongdee T. Mast cell mediators of significance in clinical practice in mastocytosis. Immunol Allergy Clin North Am. . 2018;38(3):397&#x2013;410. doi: 10.1016/j.iac.2018.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2018.04.011</ArticleId><ArticleId IdType="pubmed">30007459</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz L. B., Irani A. M., Roller K., Castells M. C., Schechter N. M. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol. . 1987;138(8):2611&#x2013;2615.</Citation><ArticleIdList><ArticleId IdType="pubmed">3549903</ArticleId></ArticleIdList></Reference><Reference><Citation>Molderings G. J. Transgenerational transmission of systemic mast cell activation disease-- genetic and epigenetic features. Transl Res. . 2016;174:86&#x2013;97. doi: 10.1016/j.trsl.2016.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2016.01.001</ArticleId><ArticleId IdType="pubmed">26880691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H. S., Kawakami Y., Kasakura K., Kawakami T. Recent advances in mast cell activation and regulation. F1000Res . 2020;9:p. 196. doi: 10.12688/f1000research.22037.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.22037.1</ArticleId><ArticleId IdType="pmc">PMC7096214</ArticleId><ArticleId IdType="pubmed">32226609</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada Y., Kosaka K., Miyazawa T., Kurata-Miura K., Yoshida T. miR-142-3p enhances Fc&#x3b5;RI-mediated degranulation in mast cells. Biochem Biophys Res Commun. . 2014;443(3):980&#x2013;986. doi: 10.1016/j.bbrc.2013.12.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2013.12.078</ArticleId><ArticleId IdType="pubmed">24361879</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao Y., Wang S., Gao Y., et al. MicroRNA-126 accelerates IgE-mediated mast cell degranulation associated with the PI3K/Akt signaling pathway by promoting Ca2+ influx. Exp Ther Med. . 2018;16(3):2763&#x2013;2769. doi: 10.3892/etm.2018.6510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6510</ArticleId><ArticleId IdType="pmc">PMC6122504</ArticleId><ArticleId IdType="pubmed">30186504</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayoral R. J., Pipkin M. E., Pachkov M., van Nimwegen E., Rao A., Monticelli S. MicroRNA-221-222 regulate the cell cycle in mast cells. J Immunol. . 2009;182(1):433&#x2013;445. doi: 10.4049/jimmunol.182.1.433.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.182.1.433</ArticleId><ArticleId IdType="pmc">PMC2610349</ArticleId><ArticleId IdType="pubmed">19109175</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Yin T., Fang F., et al. Potential risks of SARS-CoV-2 infection on reproductive health. Reprod Biomed Online. . 2020;41(1):89&#x2013;95. doi: 10.1016/j.rbmo.2020.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2020.04.018</ArticleId><ArticleId IdType="pmc">PMC7192111</ArticleId><ArticleId IdType="pubmed">32466994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantroo V., Bhattacharya S., Dhingra A., Kalra S. Pulmocrinology: interplay of pulmonary and endocrine diseases. J Pak Med Assoc. . 2021;71(3):1033&#x2013;1038.</Citation><ArticleIdList><ArticleId IdType="pubmed">34057973</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciarambino T., Para O., Giordano M. Immune system and COVID-19 by sex differences and age. Womens Health . 2021;17:p. 174550652110222. doi: 10.1177/17455065211022262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17455065211022262</ArticleId><ArticleId IdType="pmc">PMC8188967</ArticleId><ArticleId IdType="pubmed">34096383</ArticleId></ArticleIdList></Reference><Reference><Citation>Selek A., G&#xfc;&#xe7;l&#xfc; M., Bolu &#x15e;. E. COVID-19 pandemic: what about the gonads? Hormones . 2021;20(2):259&#x2013;268. doi: 10.1007/s42000-021-00277-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42000-021-00277-3</ArticleId><ArticleId IdType="pmc">PMC7966898</ArticleId><ArticleId IdType="pubmed">33730355</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Chen G., Hou H., et al. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod Biomed Online. . 2021;42(1):260&#x2013;267. doi: 10.1016/j.rbmo.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7522626</ArticleId><ArticleId IdType="pubmed">33288478</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan N., Behan L. A., Owens L. The impact of the COVID-19 pandemic on women's reproductive health. Front Endocrinol . 2021;12:p. 642755. doi: 10.3389/fendo.2021.642755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.642755</ArticleId><ArticleId IdType="pmc">PMC8030584</ArticleId><ArticleId IdType="pubmed">33841334</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasiadi M., Kempuraj D., Boucher W., Kalogeromitros D., Theoharides T. C. Progesterone inhibits mast cell secretion. Int J Immunopathol Pharmacol. . 2006;19(4):787&#x2013;794. doi: 10.1177/039463200601900408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039463200601900408</ArticleId><ArticleId IdType="pubmed">17166400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasperska-Zajac A., Brzoza Z., Rogala B. Dehydroepiandrosterone and dehydroepiandrosterone sulphate in atopic allergy and chronic urticaria. Inflammation. . 2008;31(3):141&#x2013;145. doi: 10.1007/s10753-008-9059-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-008-9059-1</ArticleId><ArticleId IdType="pubmed">18288594</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppong E., Flink N., Cato A. C. Molecular mechanisms of glucocorticoid action in mast cells. Mol Cell Endocrinol. . 2013;380(1-2):119&#x2013;126. doi: 10.1016/j.mce.2013.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2013.05.014</ArticleId><ArticleId IdType="pubmed">23707629</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M., Capellino S., Sulli A., et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci. . 2006;1089(1):538&#x2013;547. doi: 10.1196/annals.1386.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1386.043</ArticleId><ArticleId IdType="pubmed">17261796</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacenik D., Krajewska W. M. Significance of G protein-coupled estrogen receptor in the pathophysiology of irritable bowel syndrome, inflammatory bowel diseases and colorectal cancer. Front Endocrinol . 2020;11:p. 390. doi: 10.3389/fendo.2020.00390.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00390</ArticleId><ArticleId IdType="pmc">PMC7303275</ArticleId><ArticleId IdType="pubmed">32595606</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J., Liu D. Does GPER really function as a G protein-coupled estrogen receptor in vivo? Front Endocrinol . 2020;11:p. 148. doi: 10.3389/fendo.2020.00148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00148</ArticleId><ArticleId IdType="pmc">PMC7137379</ArticleId><ArticleId IdType="pubmed">32296387</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupo M., Maggiolini M., Musti A. M. GPER mediates non-genomic effects of estrogen. Methods Mol Biol. . 2016;1366:471&#x2013;488. doi: 10.1007/978-1-4939-3127-9_37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3127-9_37</ArticleId><ArticleId IdType="pubmed">26585158</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-de-Arellano A., Guti&#xe9;rrez-Franco J., Sierra-Diaz E., Pereira-Su&#xe1;rez A. L. The role of estradiol in the immune response against COVID-19. Hormones (Athens). . 2021;20(4):657&#x2013;667. doi: 10.1007/s42000-021-00300-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42000-021-00300-7</ArticleId><ArticleId IdType="pmc">PMC8210971</ArticleId><ArticleId IdType="pubmed">34142358</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R., Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. . 2020;43(7):1027&#x2013;1031. doi: 10.1007/s40618-020-01276-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01276-8</ArticleId><ArticleId IdType="pmc">PMC7195612</ArticleId><ArticleId IdType="pubmed">32361826</ArticleId></ArticleIdList></Reference><Reference><Citation>Lania A., Sandri M. T., Cellini M., Mirani M., Lavezzi E., Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. . 2020;183(4):381&#x2013;387. doi: 10.1530/EJE-20-0335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0335</ArticleId><ArticleId IdType="pmc">PMC9494315</ArticleId><ArticleId IdType="pubmed">32698147</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller I., Cannavaro D., Dazzi D., et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. . 2020;8(9):739&#x2013;741. doi: 10.1016/S2213-8587(20)30266-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30266-7</ArticleId><ArticleId IdType="pmc">PMC7392564</ArticleId><ArticleId IdType="pubmed">32738929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zdor V. V., Geltser B. I., Eliseikina M. G., et al. Roles of thyroid hormones, mast cells, and inflammatory mediators in the initiation and progression of autoimmune thyroid diseases. Int Arch Allergy Immunol. . 2020;181(9):715&#x2013;726. doi: 10.1159/000508937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000508937</ArticleId><ArticleId IdType="pubmed">32640447</ArticleId></ArticleIdList></Reference><Reference><Citation>Landucci E., Laurino A., Cinci L., Gencarelli M., Raimondi L. Thyroid hormone, thyroid hormone metabolites and mast cells: a less explored issue. Front Cell Neurosci . 2019;13:p. 79. doi: 10.3389/fncel.2019.00079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00079</ArticleId><ArticleId IdType="pmc">PMC6449760</ArticleId><ArticleId IdType="pubmed">30983971</ArticleId></ArticleIdList></Reference><Reference><Citation>Szukiewicz D., Stangret A., Ruiz-Ruiz C., et al. Estrogen- and progesterone (P4)-mediated epigenetic modifications of endometrial stromal cells (EnSCs) and/or mesenchymal stem/stromal cells (MSCs) in the etiopathogenesis of endometriosis. Stem Cell Rev Rep. . 2021;17(4):1174&#x2013;1193. doi: 10.1007/s12015-020-10115-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-10115-5</ArticleId><ArticleId IdType="pmc">PMC8316205</ArticleId><ArticleId IdType="pubmed">33411206</ArticleId></ArticleIdList></Reference><Reference><Citation>Moazzami B., Chaichian S., Samie S., et al. Does endometriosis increase susceptibility to COVID-19 infections? A case-control study in women of reproductive age. BMC Womens Health. . 2021;21(1):p. 119. doi: 10.1186/s12905-021-01270-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12905-021-01270-z</ArticleId><ArticleId IdType="pmc">PMC7983080</ArticleId><ArticleId IdType="pubmed">33752656</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi M., Horne A. W., Vincent K., et al. Self-management strategies to consider to combat endometriosis symptoms during the COVID-19 pandemic. Hum Reprod Open . 2020;2020(2, article hoaa028) doi: 10.1093/hropen/hoaa028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hropen/hoaa028</ArticleId><ArticleId IdType="pmc">PMC7263080</ArticleId><ArticleId IdType="pubmed">32509977</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi M., Horne A. W., Armour M., et al. Endometriosis and the coronavirus (COVID-19) pandemic: clinical advice and future considerations. Front. Reprod. Health . 2020;2 doi: 10.3389/frph.2020.00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/frph.2020.00005</ArticleId><ArticleId IdType="pmc">PMC9580813</ArticleId><ArticleId IdType="pubmed">36304710</ArticleId></ArticleIdList></Reference><Reference><Citation>Agolli A., Yukselen Z., Agolli O., et al. SARS-CoV-2 effect on male infertility and its possible pathophysiological mechanisms. Discoveries . 2021;9(2, article e131) doi: 10.15190/d.2021.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.15190/d.2021.10</ArticleId><ArticleId IdType="pmc">PMC8605861</ArticleId><ArticleId IdType="pubmed">34816001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardestani Zadeh A., Arab D. COVID-19 and male reproductive system: pathogenic features and possible mechanisms. J Mol Histol. . 2021;52(5):869&#x2013;878. doi: 10.1007/s10735-021-10003-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10735-021-10003-3</ArticleId><ArticleId IdType="pmc">PMC8260577</ArticleId><ArticleId IdType="pubmed">34232425</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Yang Q., Ren X., et al. Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and _in vitro_ fertilization outcomes: a retrospective cohort study. EClinicalMedicine. . 2021;38:p. 101013. doi: 10.1016/j.eclinm.2021.101013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101013</ArticleId><ArticleId IdType="pmc">PMC8259363</ArticleId><ArticleId IdType="pubmed">34250457</ArticleId></ArticleIdList></Reference><Reference><Citation>Zupin L., Pascolo L., Zito G., Ricci G., Crovella S. SARS-CoV-2 and the next generations: which impact on reproductive tissues? J Assist Reprod Genet. . 2020;37(10):2399&#x2013;2403. doi: 10.1007/s10815-020-01917-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10815-020-01917-0</ArticleId><ArticleId IdType="pmc">PMC7419027</ArticleId><ArticleId IdType="pubmed">32783136</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosma S., Carosso A. R., Cusato J., et al. Coronavirus disease 2019 and first-trimester spontaneous abortion: a case- control study of 225 pregnant patients. Am J Obstet Gynecol . 2021;224(4):391.e1&#x2013;391.e7. doi: 10.1016/j.ajog.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7543983</ArticleId><ArticleId IdType="pubmed">33039396</ArticleId></ArticleIdList></Reference><Reference><Citation>la Cour Freiesleben N., Egerup P., Hviid K. V. R., et al. SARS-CoV-2 in first trimester pregnancy: a cohort study. Human Reproduction . 2020;36(1):40&#x2013;47. doi: 10.1093/humrep/deaa311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/deaa311</ArticleId><ArticleId IdType="pmc">PMC7665455</ArticleId><ArticleId IdType="pubmed">33145598</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil A., Kalafat E., Benlioglu C., et al. SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine. . 2020;25:p. 100446. doi: 10.1016/j.eclinm.2020.100446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100446</ArticleId><ArticleId IdType="pmc">PMC7334039</ArticleId><ArticleId IdType="pubmed">32838230</ArticleId></ArticleIdList></Reference><Reference><Citation>Weatherbee B. A. T., Glover D. M., Zernicka-Goetz M. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester. Open Biol. . 2020;10(8):p. 200162. doi: 10.1098/rsob.200162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200162</ArticleId><ArticleId IdType="pmc">PMC7479935</ArticleId><ArticleId IdType="pubmed">32750256</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell . 2020;181(2):271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Goad J., Rudolph J., Rajkovic A. Female reproductive tract has low concentration of SARS-CoV2 receptors. PLoS One. . 2020;15(12, article e0243959) doi: 10.1371/journal.pone.0243959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243959</ArticleId><ArticleId IdType="pmc">PMC7735593</ArticleId><ArticleId IdType="pubmed">33315943</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilella F., Wang W., Moreno I., Roson B., Quake S. R., Simon C. Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium. Hum Reprod. . 2021;36(10):2709&#x2013;2719. doi: 10.1093/humrep/deab183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/deab183</ArticleId><ArticleId IdType="pmc">PMC8385818</ArticleId><ArticleId IdType="pubmed">34329437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M., Ma L., Xue L., et al. Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: identification of cell types and trends with age. Genomics. . 2021;113(6):3449&#x2013;3460. doi: 10.1016/j.ygeno.2021.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2021.08.012</ArticleId><ArticleId IdType="pmc">PMC8372464</ArticleId><ArticleId IdType="pubmed">34418496</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadanec L. K., McSweeney K. R., Qaradakhi T., Ali B., Zulli A., Apostolopoulos V. Can SARS-CoV-2 virus use multiple receptors to enter host cells? Int J Mol Sci. . 2021;22(3):p. 992. doi: 10.3390/ijms22030992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22030992</ArticleId><ArticleId IdType="pmc">PMC7863934</ArticleId><ArticleId IdType="pubmed">33498183</ArticleId></ArticleIdList></Reference><Reference><Citation>Rad H. S., R&#xf6;hl J., Stylianou N., et al. The effects of COVID-19 on the placenta during pregnancy. Front Immunol. . 2021;12:p. 743022. doi: 10.3389/fimmu.2021.743022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.743022</ArticleId><ArticleId IdType="pmc">PMC8479199</ArticleId><ArticleId IdType="pubmed">34603330</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallarek A. C., Urbschat C., Fonseca Brito L., et al. Inefficient placental virus replication and absence of neonatal cell-specific immunity upon Sars-CoV-2 infection during pregnancy. Front Immunol. . 2021;12:p. 698578. doi: 10.3389/fimmu.2021.698578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.698578</ArticleId><ArticleId IdType="pmc">PMC8211452</ArticleId><ArticleId IdType="pubmed">34149740</ArticleId></ArticleIdList></Reference><Reference><Citation>Saji F., Koyama M., Matsuzaki N. Current topic: human placental Fc receptors. Placenta. . 1994;15(5):453&#x2013;466. doi: 10.1016/s0143-4004(05)80415-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0143-4004(05)80415-1</ArticleId><ArticleId IdType="pubmed">7997446</ArticleId></ArticleIdList></Reference><Reference><Citation>Beesley M. A., Davidson J. R., Panariello F., et al. COVID-19 and vertical transmission: assessing the expression of ACE2/TMPRSS2 in the human fetus and placenta to assess the risk of SARS-CoV-2 infection. BJOG . 2022;129(2):256&#x2013;266. doi: 10.1111/1471-0528.16974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.16974</ArticleId><ArticleId IdType="pmc">PMC8652560</ArticleId><ArticleId IdType="pubmed">34735736</ArticleId></ArticleIdList></Reference><Reference><Citation>Faure-Bardon V., Isnard P., Roux N., et al. Protein expression of angiotensin-converting enzyme 2, a SARS-CoV-2-specific receptor, in fetal and placental tissues throughout gestation: new insight for perinatal counseling. Ultrasound Obstet Gynecol. . 2021;57(2):242&#x2013;247. doi: 10.1002/uog.22178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.22178</ArticleId><ArticleId IdType="pmc">PMC7461228</ArticleId><ArticleId IdType="pubmed">32798244</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Chen L., Zhang J., Xiong C., Li X. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One. . 2020;15(4, article e0230295) doi: 10.1371/journal.pone.0230295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0230295</ArticleId><ArticleId IdType="pmc">PMC7161957</ArticleId><ArticleId IdType="pubmed">32298273</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouachba A., Allias F., Nadaud B., et al. Placental lesions and SARS-Cov-2 infection: diffuse placenta damage associated to poor fetal outcome. Placenta. . 2021;112:97&#x2013;104. doi: 10.1016/j.placenta.2021.07.288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2021.07.288</ArticleId><ArticleId IdType="pmc">PMC8280612</ArticleId><ArticleId IdType="pubmed">34329973</ArticleId></ArticleIdList></Reference><Reference><Citation>Linehan L., O'Donoghue K., Dineen S., White J., Higgins J. R., Fitzgerald B. SARS-CoV-2 placentitis: an uncommon complication of maternal COVID-19. Placenta. . 2021;104:261&#x2013;266. doi: 10.1016/j.placenta.2021.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2021.01.012</ArticleId><ArticleId IdType="pmc">PMC7832228</ArticleId><ArticleId IdType="pubmed">33465727</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X. Y., Jia X. M., Jia Y. S., Chen X. R., Wang H. Z., Qi W. Q. Development and distribution of mast cells and neuropeptides in human fetus duodenum. World J Gastroenterol. . 2004;10(22):3349&#x2013;3352. doi: 10.3748/wjg.v10.i22.3249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v10.i22.3249</ArticleId><ArticleId IdType="pmc">PMC4572311</ArticleId><ArticleId IdType="pubmed">15484316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz E. I., Herrera E., De La Torre A., Royal College of Obstetricians and Gynaecologists Coronavirus (COVID-19) infection and pregnancy. Colombia M&#xe9;dica . 2020;51</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518733</ArticleId><ArticleId IdType="pubmed">33012886</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L. B., Weinstock L. B., Molderings G. J. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. . 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Allotey J., Stallings E., Bonet M., et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. The BMJ . 2021;370</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7459193</ArticleId><ArticleId IdType="pubmed">32873575</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A. B., Harrison E. M., Green C. A., et al. Features of 20&#x2009;133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. . 2020;369:p. m1985. doi: 10.1136/bmj.m1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Collin J., Bystr&#xf6;m E., Carnahan A., Ahrne M. Public Health Agency of Sweden's Brief Report: pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden. Acta Obstet Gynecol Scand. . 2020;99(7):819&#x2013;822. doi: 10.1111/aogs.13901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aogs.13901</ArticleId><ArticleId IdType="pmc">PMC7273089</ArticleId><ArticleId IdType="pubmed">32386441</ArticleId></ArticleIdList></Reference><Reference><Citation>Peddapalli A., Gehani M., Kalle A. M., Peddapalli S. R., Peter A. E., Sharad S. Demystifying excess immune response in COVID-19 to reposition an orphan drug for down-regulation of NF-&#x3ba;B: a systematic review. Viruses. . 2021;13(3):p. 378. doi: 10.3390/v13030378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030378</ArticleId><ArticleId IdType="pmc">PMC7997247</ArticleId><ArticleId IdType="pubmed">33673529</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L. B., Dempsey T. T., Rosenthal L. S., Dorff S. R. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding. J Obstet Gynaecol. . 2019;39(5):664&#x2013;669. doi: 10.1080/01443615.2018.1550475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01443615.2018.1550475</ArticleId><ArticleId IdType="pubmed">30964355</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorff S. R., Afrin L. B. Mast cell activation syndrome in pregnancy, delivery, postpartum and lactation: a narrative review. J Obstet Gynaecol. . 2020;40(7):889&#x2013;901. doi: 10.1080/01443615.2019.1674259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01443615.2019.1674259</ArticleId><ArticleId IdType="pubmed">32148151</ArticleId></ArticleIdList></Reference><Reference><Citation>Acanfora D., Acanfora C., Ciccone M. M., et al. The cross-talk between thrombosis and inflammatory storm in acute and long-COVID-19: therapeutic targets and clinical cases. Viruses. . 2021;13(10):p. 1904. doi: 10.3390/v13101904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101904</ArticleId><ArticleId IdType="pmc">PMC8540492</ArticleId><ArticleId IdType="pubmed">34696334</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanchal S., Mishra A., Singh M. K., Ashraf M. Z. Understanding inflammatory responses in the manifestation of prothrombotic phenotypes. Frontiers in Cell and Developmental Biology . 2020;8:p. 73. doi: 10.3389/fcell.2020.00073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00073</ArticleId><ArticleId IdType="pmc">PMC7033430</ArticleId><ArticleId IdType="pubmed">32117993</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazrafkan M., Hosseini E., Nazari M., Amorim C. A., Sadeghi M. R. NLRP3 inflammasome: a joint, potential therapeutic target in management of COVID-19 and fertility problems. Journal of Reproductive Immunology . 2021;148:p. 103427. doi: 10.1016/j.jri.2021.103427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jri.2021.103427</ArticleId><ArticleId IdType="pmc">PMC8453780</ArticleId><ArticleId IdType="pubmed">34563758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Wang F., Zhang Y. Expression and contribution of NLRP3 inflammasome during the follicular development induced by PMSG. Frontiers in Cell and Developmental Biology . 2019;7:p. 256. doi: 10.3389/fcell.2019.00256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00256</ArticleId><ArticleId IdType="pmc">PMC6842944</ArticleId><ArticleId IdType="pubmed">31750302</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>